AL
SIOX

Airain Ltd’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Airain Ltd’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,511
Closed -$139K – 955
2016
Q1 		$139K Buy
+1,511
New +$161K 0.01% 718

Other funds holding SIOX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ZBI
Ziff Brothers Investments New York $267M AUM 49.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Airain Ltd's SIOX Position: Q2 2016 in Review

Airain Ltd sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2016, closing a stake of 1,511 shares — an estimated $139K sold.

Airain Ltd first reported a position in SIOX in Q1 2016 and held it in 1 quarter. The position peaked at $139K in Q1 2016. 81 funds tracked by Wall St. Rank hold SIOX as of Q2 2016.

  • Airain Ltd reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Airain Ltd sold 1,511 Sio Gene Therapies Inc. Common Stock shares in Q2 2016, an estimated $139K.
  • Airain Ltd first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Airain Ltd's Sio Gene Therapies Inc. Common Stock position peaked at $139K in Q1 2016.
  • 81 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2016.

Based on Airain Ltd's 13F filing for Q2 2016, filed 5 Aug 2016.